Actively Recruiting
Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial
Led by Yunxuan Li · Updated on 2025-11-28
250
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to test whether a communication strategy called "linguistic nudging" can help doctors and patients with type 2 diabetes make better treatment decisions together, and whether this improves patients' ability to manage their condition. What will happen in the study? - 250 adults with type 2 diabetes from Xiang'an Hospital (Xiamen) will be randomly assigned to one of two groups: Intervention group:Doctors will receive special training in "linguistic nudging" techniques to encourage shared decision-making. Patients will use a mobile app to record medication preferences, and doctors will adjust advice based on these preferences. Control group:Patients will receive standard diabetes care without these additional strategies. \- All participants will be followed for 6 months. What is the study aiming to find out? The main goal is to see if patients in the intervention group: Better follow medication plans Improve blood sugar monitoring Have better blood sugar control Feel more satisfied with doctor-patient communication Why is this important? Good self-management is key to controlling diabetes, but many patients struggle with it. Effective communication during shared decision-making may empower patients to manage their condition day-to-day with greater confidence. Patient safety and rights: Participation is completely voluntary All personal information will be kept strictly confidential Medical support will be provided if any health problems occur during the study Participants may withdraw at any time This research has been approved by the Ethics Committee of Xiang'an Hospital (Approval date: October 2025).
CONDITIONS
Official Title
Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of type 2 diabetes
- Age 18 years or older
- Normal cognitive function with Mini-Cog score of 3 or above
- Can independently use a smartphone and WeChat app
- Willing to participate and able to sign informed consent
You will not qualify if you...
- Severe acute complications like ketoacidosis or hyperosmolar coma
- Documented cognitive impairment such as dementia or Alzheimer's disease
- Currently involved in other clinical trials
- Life expectancy less than 6 months
- Pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xiang'an Hospital Affiliated to Xiamen University
Xiamen, Fujian, China, 0592361101
Actively Recruiting
Research Team
W
Wei WANG, M.D.
CONTACT
Y
Yunxuan Li, Master Candidate
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here